China Pharma Holdings
Filed with the SEC on · accession 0001213900-26-118012
CPHI filed a DEF 14A (proxy statement) with the SEC on Nov 10, 2026. Information for the shareholder meeting: votes, board members and executive pay. The stock moved -2.5% by the first close after the filing.
China Pharma Holdings filed a definitive proxy statement for its annual meeting seeking shareholder approval for a reverse stock split at a ratio of up to 1:50, along with the election of three independent directors and an amendment to its long-term incentive plan.
Close before
$0.56
Nov 9, 2026
First close after
-2.48%
$0.55
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CPHI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CPHI?
Click hereCPHI filed a DEF 14A (Stock split). China Pharma Holdings filed a definitive proxy statement for its annual meeting seeking shareholder approval for a reverse stock split at a ratio of up to 1:50, along with the election of three independent directors and an amendment to its long-term incentive plan.
Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.
Information for the shareholder meeting: votes, board members and executive pay. Executive pay tables show how management is paid. Check the items shareholders vote on (mergers, new share plans).
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A DEF 14A (proxy statement): Information for the shareholder meeting: votes, board members and executive pay.
CPHI closed at $0.56 before the filing and $0.55 on Nov 10, 2026 (-2.48%).
Get alerts when CPHI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days